You may know Psychedelic Invest for our trackable index of public companies. You may know us for our constant stream of informative content surrounding...
Some analysts have called the industry's business model problematic. The post Despite Psychedelic Industry Buzz, Some Have Crashed Already appeared first...
With all the twists and turns coming from the U.S. federal government, decriminalization and legalization of psychedelics advancing all across the country,...
The article 2022 End of Year Review: Cybin was originally published on Microdose. The end of the year is a convenient time to look back and...
Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.
TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug...
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) today issued...
The article Predicting Psychedelic Outcomes was originally published on Microdose. One of the hardest parts about taking psychedelics is entering the...
Pharmaceutical Grade Psilocybin Synthesized By Mindset’s Patent Pending ProcessTORONTO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:...
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...